Clinical Trials Browser

COVID-19, Kidney Neoplasms, Prostatic Neoplasms, Urogenital Neoplasms

NCT04761107 2025-01-31

Impact of COVID-19 on GU Disease

COVID-19, Urinary Bladder Neoplasms, Kidney Calculi, Kidney Neoplasms, Prostatic Hyperplasia, Prostatic Neoplasms, Urinary Tract Infections, Urogenital Neoplasms

NCT05083143 2022-04-27

The Impact of the COVID-19 Pandemic on Testicular Cancer

Completed

50 enrolled

Genitourinary

COVID-19, Testicular Neoplasms

NCT04446429 2021-12-10

Anti-Androgen Treatment for COVID-19

Phase NA Completed

268 enrolled 8 charts

Genitourinary

COVID-19, Alopecia, Prostatic Hyperplasia, Prostatic Neoplasms, Severe Acute Respiratory Syndrome

NCT04900259 2021-10-06

The Effect of the COVID-19 Pandemic on Primary Bladder Cancer Presentations

Completed

183 enrolled

Genitourinary

COVID-19, Urinary Bladder Neoplasms

NCT05009186 2021-08-17

Changing of Prostate Specific Antigen Value in Patients With Covid-19

Phase NA Unknown

100 enrolled

Genitourinary

COVID-19, Prostatic Neoplasms

NCT04834089 2021-04-08

SOROCOV

Phase 1/2 Unknown

618 enrolled

Genitourinary

COVID-19, Cardiovascular Diseases, Diabetes Mellitus, Kidney Diseases, Neoplasms, Pulmonary Disease, Chronic Obstructive

NCT04361552 2020-06-18

Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)

Phase 3 Withdrawn

Genitourinary

COVID-19, Coronary Artery Disease, Diabetes Mellitus, Kidney Failure, Chronic, Neoplasms, Stroke, Pulmonary Disease, Chronic Obstructive

Clinical Trials

SOGUGCOVID

Impact of COVID-19 on GU Disease

The Impact of the COVID-19 Pandemic on Testicular Cancer

Anti-Androgen Treatment for COVID-19

The Effect of the COVID-19 Pandemic on Primary Bladder Cancer Presentations

Changing of Prostate Specific Antigen Value in Patients With Covid-19

SOROCOV

Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)